BioLife Solutions, Inc. Deferred Tax Assets, Tax Credit Carryforwards
BioLife Solutions, Inc. (BLFS) had Deferred Tax Assets, Tax Credit Carryforwards of $2.80 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxCreditCarryforwards · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Tax Credit Carryforwards $2.80M.
- 2024-12-31: Deferred Tax Assets, Tax Credit Carryforwards $2.69M.
- 2023-12-31: Deferred Tax Assets, Tax Credit Carryforwards $2.23M.
- 2022-12-31: Deferred Tax Assets, Tax Credit Carryforwards $1.42M.
| Period end | Deferred Tax Assets, Tax Credit Carryforwards |
|---|---|
| 2025-12-31 | $2.80M 10-K · filed 2026-02-26 |
| 2024-12-31 | $2.69M 10-K · filed 2026-02-26 |
| 2023-12-31 | $2.23M 10-K · filed 2025-03-03 |
| 2022-12-31 | $1.42M 10-K · filed 2024-02-29 |
| 2021-12-31 | $594.00K 10-K · filed 2023-03-31 |
| 2020-12-31 | $225.00K 10-K · filed 2022-03-31 |
| 2019-12-31 | $152.00K 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |